Academic

At TBSI, we aim to cultivate strategic partnerships with institutions of significant scale and impact, fostering collaborations that drive internationally leading research with profound scientific, societal, and economic benefits.

Home to 75 Principal Investigators and over 700 researchers, TBSI focuses on groundbreaking discoveries in a multidisciplinary environment, addressing critical human diseases. Recent advancements include significant progress in cancer, asthma, Type 2 diabetes, age-related macular degeneration, and infectious diseases such as hepatitis C and motor neuron disease.

In the past decade, TBSI has produced over 1,600 research papers published in internationally renowned journals, including Nature, Science, Cell, Nature Medicine, Nature Immunology, Nature Neuroscience, and The Lancet. This growth reflects both robust funding and impactful discoveries.